Accretion Pharmaceuticals

63.75
-1.85
(-2.82%)
Market Cap
70.90 Cr
EPS
8.48
PE Ratio
10.43
Dividend Yield
0.00 %
Industry
-
52 Week High
82.95
52 Week Low
62.55
PB Ratio
1.57
Debt to Equity
2.46
Sector
-
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Forecast
Actual
Growth Rate
Revenue Growth
-
Net Income Growth
-
Cash Flow Change
-135.88 %
ROE
-
ROCE
-
EBITDA Margin (Avg.)
-

Yearly Financial Results

Annual Financials
2024
2025
TTM
Revenue
13
57
0
Expenses
11
46
0
EBITDA
3
12
0
Operating Profit %
20 %
21 %
0 %
Depreciation
0
1
0
Interest
1
1
0
Profit Before Tax
2
10
0
Tax
1
3
0
Net Profit
2
7
0
EPS in ₹
11.08
8.48
0.00

Balance Sheet

Balance Sheet
2024
2025
Total Assets
27
40
Fixed Assets
5
6
Current Assets
22
34
Capital Work in Progress
0
0
Investments
0
21
Other Assets
22
0
Total Liabilities
27
40
Current Liabilities
15
23
Non Current Liabilities
7
1
Total Equity
6
15
Reserve & Surplus
2
7
Share Capital
4
8

Cash Flow

Cash Flow
2024
Net Cash Flow
0
Investing Activities
-6
Operating Activities
-11
Financing Activities
17

Share Holding

% Holding
Sept 2024
Jan 2025
May 2025
Promoter
100.00 %
100.00 %
73.50 %
FIIs
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
0.00 %
19.44 %
Others
0.00 %
0.00 %
7.06 %
No of Share Holders
8
8
8

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
11 Jun 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
11 Jun 2025 66.05 69.80

Technical Indicators

RSI(14)
Neutral
25.73
ATR(14)
Volatile
3.29
STOCH(9,6)
Neutral
25.27
STOCH RSI(14)
Oversold
0.00
MACD(12,26)
Bearish
-0.75
ADX(14)
Weak Trend
20.61
UO(9)
Bearish
47.18
ROC(12)
Downtrend And Accelerating
-10.08
WillR(14)
Neutral
-71.15